Bruker Corp (NASDAQ:BRKR)
| 43.69 BATS BZX Real-Time Price As of 12:29pm ET |  +0.18 / +0.41%Today’s Change | 30.78 Today|||52-Week Range 54.49 | -14.28% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $6.9B |
Company Description
Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI), and Bruker Energy and Supercon Technologies (BEST) segments. The BSI segment comprises of the Bruker BioSpin Group, the Bruker CALID Group, and the Bruker Nano Group. The BEST segment designs, manufactures, and distributes superconducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications. The company was founded by Gunther Laukien in 1961 and is headquartered in Billerica, MA.
Contact Information
Bruker Corp. 40 Manning Road Billerica Massachusetts 01821 |
Employees
Shareholders
| Individual stakeholders | 65.31% |
| Mutual fund holders | 50.83% |
| Other institutional | 19.50% |
Top Executives
| Frank H. Laukien | Chairman, President & Chief Executive Officer |
| Gerald N. Herman | CFO, Principal Accounting Officer & VP |
| Mark Robert Munch | Executive Vice President |
| Jürgen Srega | Group President-Bruker CALID Segment |
| Falko Busse | President-Bruker BioSpin Group |
